Press Resease

Critical Care Diagnostics Market - Global Industry Analysis

Critical Care Diagnostics Market by Type (Routine & Special Chemistry, Coagulation Test, Microbial & Infectious Diseases, Immunoproteins, Hematology, Flow Cytometry, and Others), by End Use (Emergency Rooms, Operating Rooms, Icus and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 06-Sep-2021 Category: Medical Device Report Format : PDF Pages: 155 Report Code: ZMR-6124 Status : Published

The critical care diagnostics market accounted for USD 1.2 Billion in 2020 and is expected to reach USD 1.9 Billion by 2028, growing at a CAGR of 6.2 % from 2021 to 2028.

Description

Market Overview

The critical care diagnostics market accounted for USD 1.2 Billion in 2020 and is expected to reach USD 1.9 Billion by 2028, growing at a CAGR of 6.2 % from 2021 to 2028.

Critical care is medical care for people with life-threatening illness and injuries. Such patients are managed in intensive care units. To stabilize the functioning of the organs and improve patient conditions, advanced diagnostic technology is required for the treatment. Critical care diagnostics plays a vital role in the rapid diagnosis which enables the healthcare provider to take quick and appropriate decisions regarding the treatment of the patients.

COVID-19 Impact Analysis

As due to the COVID 19 pandemic, majorly every industry was shut for a significant amount of time. The Covid-19 pandemic has put a lot of strain on the healthcare industry as well. The coronavirus has infected millions of people all across the world. The majority of those infected with Covid-19 experienced dyspnoea, necessitating the use of ventilators and hospitalisation in the intensive care unit. For these people, a diagnostic test is required. During the Covid-19 pandemic, the worldwide critical care diagnostics market grew at a notable rate, and it is likely to continue growing at a significant rate in the coming years.

Growth Factors

There are various factors leading to the growth of the critical care diagnostics market. The growing need for speedy and precise diagnosis, the rise in the incidence of chronic and infectious diseases, and the rise in the elderly population are all factors driving the global market forward. As a result of all of these factors, demand for critical care diagnostics is increasing, fuelling the worldwide critical care diagnostics market's growth. Furthermore, expanding healthcare infrastructure and scientific advancements in critical care diagnostics are two aspects that are propelling the industry forward. Additionally, technological improvements that increase the efficiency and efficacy of diagnostic tests may provide sufficient chances for the worldwide critical care diagnostics market to grow.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Type Segment Analysis Preview

Due to an increase in demand for speedy and accurate early diagnosis as well as the capacity to minimise patient recovery time, the immunoproteins segment of this market is expected to account for the highest share in terms of value. The need for these diagnostics has increased as patient awareness of better healthcare options has improved and physician expertise of target therapy has improved. Clinical chemistry, flow cytometer testing, and coagulation tests, among other things, are driving the expansion of the entire industry. Microbiology and infectious disease testing, as well as immunoproteins, are expected to fuel segment growth.

End Segment Analysis Preview

Critical care diagnostics are commonly seen in hospital ancillary areas such as emergency rooms, operating rooms, and intensive care units (ICUs), among other places. The market's growth has been affected by the growing acceptance of telemedicine and increased knowledge of improved diagnostics tools. During the projection period, the utilisation of emergency rooms in this diagnostics market is likely to boost segment growth.

Regional Analysis Preview

The Asia Pacific region is projected to grow at a CAGR of 5.4 % over the forecast period. Asia Pacific is expected to be the fastest growing region for the critical care diagnostics market. This increase can be attributed to an increase in the number of geriatrics in India, as well as an increase in the number of intensive care specialist hospitals and improved healthcare facilities in many rural areas. Furthermore, the Chinese government's recent health reforms increased patient insurance coverage and strengthened basic healthcare services.

North America is expected to be growing significantly for the critical care diagnostics market. North America is a technologically advanced region, which means the adoption rate of any new technology is very high in the region. The efficiency and efficacy of diagnostic tests may result in ample opportunities for the growth of the market in the region. This is due to an increase in the prevalence of chronic and infectious diseases, technological advancements, and well-established healthcare infrastructure.

Key Market Players & Competitive Landscape

Some of the key players in the critical care diagnostics market are Abbott Laboratories, Siemens Healthineers, F. Hoffmann-La Roche Ltd., Dickinson and Company, Beckman Coulter, Inc., Alere, Inc., Bayer AG, Bio-Rad Laboratories, Inc., Danaher Corporation, and Chembio Diagnostic Systems, Inc., among others. These companies adopt various strategies in order to boost their presence and capitalization.

The critical care diagnostics market is segmented as follows:   

 By Type

  • Routine & Special Chemistry
  • Coagulation Test
  • Microbial & Infectious Diseases
  • Immunoproteins
  • Hematology
  • Flow Cytometry
  • Others

     By End Use

  • Emergency Rooms
  • Operating Rooms
  • ICUs
  • Others

   By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Type
        • 2.1.1.2. Market Attractiveness Analysis, By End Use
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Critical Care Diagnostics Market, 2016 – 2020 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Critical Care Diagnostics Market – Type Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Type, 2020 & 2028
    • 4.2. Routine & Special Chemistry
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Coagulation Test
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Microbial & Infectious Diseases
      • 4.4.1. Market Size and Forecast, By Region (USD Million)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Immunoproteins
      • 4.5.1. Market Size and Forecast, By Region (USD Million)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.6. Hematulogy
      • 4.6.1. Market Size and Forecast, By Region (USD Million)
      • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.7. Flow Cytometry
      • 4.7.1. Market Size and Forecast, By Region (USD Million)
      • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.8. Others
      • 4.8.1. Market Size and Forecast, By Region (USD Million)
      • 4.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.8.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Critical Care Diagnostics Market – End Use Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By End Use, 2020 & 2028
    • 5.2. Emergency Rooms
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Operating Rooms
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. ICUs
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Others
      • 5.5.1. Market Size and Forecast, By Region (USD Million)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Critical Care Diagnostics Market – Regional Analysis
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2020 (USD Million)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2020 (USD Million)
      • 6.2.2. North America Market Revenue, By Type, 2016 – 2020
      • 6.2.3. North America Market Revenue, By End Use, 2016 – 2020
      • 6.2.4. U.S.
        • 6.2.4.1. U.S. Market Revenue, By Type, 2016 – 2020
        • 6.2.4.2. U.S. Market Revenue, By End Use, 2016 – 2020
      • 6.2.5. Canada
        • 6.2.5.1. Canada Market Revenue, By Type, 2016 – 2020
        • 6.2.5.2. Canada Market Revenue, By End Use, 2016 – 2020
      • 6.2.6. Mexico
        • 6.2.6.1. Mexico Market Revenue, By Type, 2016 – 2020
        • 6.2.6.2. Mexico Market Revenue, By End Use, 2016 – 2020
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2020 (USD Million)
      • 6.3.2. Europe Market Revenue, By Type, 2016 – 2020
      • 6.3.3. Europe Market Revenue, By End Use, 2016 – 2020
      • 6.3.4. Germany
        • 6.3.4.1. Germany Market Revenue, By Type, 2016 – 2020
        • 6.3.4.2. Germany Market Revenue, By End Use, 2016 – 2020
      • 6.3.5. France
        • 6.3.5.1. France Market Revenue, By Type, 2016 – 2020
        • 6.3.5.2. France Market Revenue, By End Use, 2016 – 2020
      • 6.3.6. U.K.
        • 6.3.6.1. U.K. Market Revenue, By Type, 2016 – 2020
        • 6.3.6.2. U.K. Market Revenue, By End Use, 2016 – 2020
      • 6.3.7. Italy
        • 6.3.7.1. Italy Market Revenue, By Type, 2016 – 2020
        • 6.3.7.2. Italy Market Revenue, By End Use, 2016 – 2020
      • 6.3.8. Spain
        • 6.3.8.1. Spain Market Revenue, By Type, 2016 – 2020
        • 6.3.8.2. Spain Market Revenue, By End Use, 2016 – 2020
      • 6.3.9. Rest of Europe
        • 6.3.9.1. Rest of Europe Market Revenue, By Type, 2016 – 2020
        • 6.3.9.2. Rest of Europe Market Revenue, By End Use, 2016 – 2020
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2020 (USD Million)
      • 6.4.2. Asia Pacific Market Revenue, By Type, 2016 – 2020
      • 6.4.3. Asia Pacific Market Revenue, By End Use, 2016 – 2020
      • 6.4.4. China
        • 6.4.4.1. China Market Revenue, By Type, 2016 – 2020
        • 6.4.4.2. China Market Revenue, By End Use, 2016 – 2020
      • 6.4.5. Japan
        • 6.4.5.1. Japan Market Revenue, By Type, 2016 – 2020
        • 6.4.5.2. Japan Market Revenue, By End Use, 2016 – 2020
      • 6.4.6. India
        • 6.4.6.1. India Market Revenue, By Type, 2016 – 2020
        • 6.4.6.2. India Market Revenue, By End Use, 2016 – 2020
      • 6.4.7. South Korea
        • 6.4.7.1. South Korea Market Revenue, By Type, 2016 – 2020
        • 6.4.7.2. South Korea Market Revenue, By End Use, 2016 – 2020
      • 6.4.8. South-East Asia
        • 6.4.8.1. South-East Asia Market Revenue, By Type, 2016 – 2020
        • 6.4.8.2. South-East Asia Market Revenue, By End Use, 2016 – 2020
      • 6.4.9. Rest of Asia Pacific
        • 6.4.9.1. Rest of Asia Pacific Market Revenue, By Type, 2016 – 2020
        • 6.4.9.2. Rest of Asia Pacific Market Revenue, By End Use, 2016 – 2020
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2020 (USD Million)
      • 6.5.2. Latin America Market Revenue, By Type, 2016 – 2020
      • 6.5.3. Latin America Market Revenue, By End Use, 2016 – 2020
      • 6.5.4. Brazil
        • 6.5.4.1. Brazil Market Revenue, By Type, 2016 – 2020
        • 6.5.4.2. Brazil Market Revenue, By End Use, 2016 – 2020
      • 6.5.5. Argentina
        • 6.5.5.1. Argentina Market Revenue, By Type, 2016 – 2020
        • 6.5.5.2. Argentina Market Revenue, By End Use, 2016 – 2020
      • 6.5.6. Rest of Latin America
        • 6.5.6.1. Rest of Latin America Market Revenue, By Type, 2016 – 2020
        • 6.5.6.2. Rest of Latin America Market Revenue, By End Use, 2016 – 2020
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2020 (USD Million)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Type, 2016 – 2020
      • 6.6.3. The Middle-East and Africa Market Revenue, By End Use, 2016 – 2020
      • 6.6.4. GCC Countries
        • 6.6.4.1. GCC Countries Market Revenue, By Type, 2016 – 2020
        • 6.6.4.2. GCC Countries Market Revenue, By End Use, 2016 – 2020
      • 6.6.5. South Africa
        • 6.6.5.1. South Africa Market Revenue, By Type, 2016 – 2020
        • 6.6.5.2. South Africa Market Revenue, By End Use, 2016 – 2020
      • 6.6.6. Rest of Middle-East Africa
        • 6.6.6.1. Rest of Middle-East Africa Market Revenue, By Type, 2016 – 2020
        • 6.6.6.2. Rest of Middle-East Africa Market Revenue, By End Use, 2016 – 2020
  • Chapter No. 7 Critical Care Diagnostics Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Technology Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8 Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Critical Care Diagnostics Market: Company Market Share, 2019
      • 8.1.2. Global Critical Care Diagnostics Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 8.1.3. Global Critical Care Diagnostics Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Critical Care Diagnostics Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9 Company Profiles
    • 9.1. Abbott Laboratories
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Siemens Healthineers
      • 9.3. F. Hoffmann-La Roche Ltd.
    • 9.4. Dickinson and Company
    • 9.5. Beckman Coulter, Inc.
    • 9.6. Alere, Inc.
    • 9.7. Bayer AG,
    • 9.8. Bio-Rad Laboratories, Inc.,
    • 9.9. Danaher Corporation
    • 9.10. Chembio Diagnostic Systems, Inc.
  • Chapter No. 10 Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11 Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

List of Figures 
  
FIG NO. 1. Market Attractiveness Analysis, By Type 
FIG NO. 2. Market Attractiveness Analysis, By End Use 
FIG NO. 3. Market Attractiveness Analysis, By Region 
FIG NO. 4. Global Critical Care Diagnostics Market Revenue, 2016 – 2020 (USD Million) 
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries 
FIG NO. 6. Market Revenue Share, By Type, 2020 & 2028 
FIG NO. 7. Global Critical Care Diagnostics Market for Routine & Special Chemistry, Revenue (USD Million) 2016 – 2020 
FIG NO. 8. Comparative Revenue Analysis of Critical Care Diagnostics Market for Routine & Special Chemistry, By Country, 2020 & 2028 
FIG NO. 9. Global Critical Care Diagnostics Market for Coagulation Test, Revenue (USD Million) 2016 – 2020 
FIG NO. 10. Comparative Revenue Analysis of Critical Care Diagnostics Market for Coagulation Test, By Country, 2020 & 2028 
FIG NO. 11. Global Critical Care Diagnostics Market for Microbial & Infectious Diseases, Revenue (USD Million) 2016 – 2020 
FIG NO. 12. Comparative Revenue Analysis of Critical Care Diagnostics Market for Microbial & Infectious Diseases, By Country, 2020 & 2028 
FIG NO. 13. Global Critical Care Diagnostics Market for Immunoproteins, Revenue (USD Million) 2016 – 2020 
FIG NO. 14. Comparative Revenue Analysis of Critical Care Diagnostics Market for Immunoproteins, By Country, 2020 & 2028 
FIG NO. 15. Global Critical Care Diagnostics Market for Hematology, Revenue (USD Million) 2016 – 2020 
FIG NO. 16. Comparative Revenue Analysis of Critical Care Diagnostics Market for Hematology, By Country, 2020 & 2028 
FIG NO. 17. Global Critical Care Diagnostics Market for Flow Cytometry, Revenue (USD Million) 2016 – 2020 
FIG NO. 18. Comparative Revenue Analysis of Critical Care Diagnostics Market for Flow Cytometry, By Country, 2020 & 2028 
FIG NO. 19. Global Critical Care Diagnostics Market for Others, Revenue (USD Million) 2016 – 2020 
FIG NO. 20. Comparative Revenue Analysis of Critical Care Diagnostics Market for Others, By Country, 2020 & 2028 
FIG NO. 21. Market Revenue Share, By End Use, 2020 & 2028 
FIG NO. 22. Global Critical Care Diagnostics Market for Emergency Rooms, Revenue (USD Million) 2016 – 2020 
FIG NO. 23. Comparative Revenue Analysis of Critical Care Diagnostics Market for Emergency Rooms, By Country, 2020 & 2028 
FIG NO. 24. Global Critical Care Diagnostics Market for Operating Rooms, Revenue (USD Million) 2016 – 2020 
FIG NO. 25. Comparative Revenue Analysis of Critical Care Diagnostics Market for Operating Rooms, By Country, 2020 & 2028 
FIG NO. 26. Global Critical Care Diagnostics Market for ICUs, Revenue (USD Million) 2016 – 2020 
FIG NO. 27. Comparative Revenue Analysis of Critical Care Diagnostics Market for ICUs, By Country, 2020 & 2028 
FIG NO. 28. Global Critical Care Diagnostics Market for Others, Revenue (USD Million) 2016 – 2020 
FIG NO. 29. Comparative Revenue Analysis of Critical Care Diagnostics Market for Others, By Country, 2020 & 2028 
FIG NO. 30. Global Critical Care Diagnostics Market Revenue Share, By Region, 2020 & 2028 
FIG NO. 31. North America Critical Care Diagnostics Market Revenue, 2016 - 2020 (USD Million) 
FIG NO. 32. Porter’s Five Forces Analysis for Global Critical Care Diagnostics Market 
FIG NO. 33. PEST Analysis for Global Critical Care Diagnostics Market 
FIG NO. 34. Pricing Analysis for Global Critical Care Diagnostics Market 
FIG NO. 35. Value Chain Analysis for Global Critical Care Diagnostics Market 
FIG NO. 36. Company Share Analysis, 2019 
FIG NO. 37. Radar Determinant Chart, 2019 
FIG NO. 38. Company Strategic Developments – Heat Map Analysis 
FIG NO. 39. Abbott Laboratories Business Segment Revenue Share, 2020 (%) 
FIG NO. 40. Abbott Laboratories Geographical Segment Revenue Share, 2020 (%) 
FIG NO. 41. Market Channels 
FIG NO. 42. Marketing Channel Development Trend 
FIG NO. 43. Growth in World Gross Product, 2008-2018 
FIG NO. 44. Research Methodology – Detailed View 
FIG NO. 45. Research Methodology 
  
  


List of Tables 
  
TABLE NO. 1. Global Critical Care Diagnostics Market: Snapshot 
TABLE NO. 2. Quarterly Critical Care Diagnostics Market Revenue by Region, 2020 
TABLE NO. 3. Quarterly Critical Care Diagnostics Market Revenue Forecast by Region, 2021 
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million) 
TABLE NO. 6. Global Critical Care Diagnostics Market for Routine & Special Chemistry, by Region, 2016 – 2020 (USD Million) 
TABLE NO. 7. Global Critical Care Diagnostics Market for Coagulation Test, by Region, 2016 – 2020 (USD Million) 
TABLE NO. 8. Global Critical Care Diagnostics Market for Microbial & Infectious Diseases, by Region, 2016 – 2020 (USD Million) 
TABLE NO. 9. Global Critical Care Diagnostics Market for Immunoproteins, by Region, 2016 – 2020 (USD Million) 
TABLE NO. 10. Global Critical Care Diagnostics Market for Hematology, by Region, 2016 – 2020 (USD Million) 
TABLE NO. 11. Global Critical Care Diagnostics Market for Flow Cytometry, by Region, 2016 – 2020 (USD Million) 
TABLE NO. 12. Global Critical Care Diagnostics Market for Others, by Region, 2016 – 2020 (USD Million) 
TABLE NO. 13. Global Critical Care Diagnostics Market for Emergency Rooms, by Region, 2016 – 2020 (USD Million) 
TABLE NO. 14. Global Critical Care Diagnostics Market for Operating Rooms, by Region, 2016 – 2020 (USD Million) 
TABLE NO. 15. Global Critical Care Diagnostics Market for ICUs, by Region, 2016 – 2020 (USD Million) 
TABLE NO. 16. Global Critical Care Diagnostics Market for Others, by Region, 2016 – 2020 (USD Million) 
TABLE NO. 17. Global Critical Care Diagnostics Market Revenue, By Region, 2016 – 2020 (USD Million) 
TABLE NO. 18. North America Critical Care Diagnostics Market Revenue, By Country, 2016 – 2020 (USD Million) 
TABLE NO. 19. North America Critical Care Diagnostics Market Revenue, By Type, 2016 – 2020 (USD Million) 
TABLE NO. 20. North America Critical Care Diagnostics Market Revenue, By End Use, 2016 – 2020 (USD Million) 
TABLE NO. 21. U.S. Critical Care Diagnostics Market Revenue, By Type, 2016 – 2020 (USD Million) 
TABLE NO. 22. U.S. Critical Care Diagnostics Market Revenue, By End Use, 2016 – 2020 (USD Million) 
TABLE NO. 23. Canada Critical Care Diagnostics Market Revenue, By Type, 2016 – 2020 (USD Million) 
TABLE NO. 24. Canada Critical Care Diagnostics Market Revenue, By End Use, 2016 – 2020 (USD Million) 
TABLE NO. 25. Mexico Critical Care Diagnostics Market Revenue, By Type, 2016 – 2020 (USD Million) 
TABLE NO. 26. Mexico Critical Care Diagnostics Market Revenue, By End Use, 2016 – 2020 (USD Million) 
TABLE NO. 27. Drivers for the Critical Care Diagnostics Market: Impact Analysis 
TABLE NO. 28. Restraints for the Critical Care Diagnostics Market: Impact Analysis 
TABLE NO. 29. Major Buyers of Critical Care Diagnostics 
TABLE NO. 30. Distributors/Traders List of Critical Care Diagnostics 
TABLE NO. 31. Global Critical Care Diagnostics Market, Company Market Revenue, 2016 – 2019 (USD Million) 
TABLE NO. 32. Global Critical Care Diagnostics Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million) 
  
  
  


 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The critical care diagnostics market was valued at 1.2 USD Billion in 2020.

The critical care diagnostics market is expected to reach USD 1.9 Billion by 2028, growing at a CAGR of 6.2 % between 2021 to 2028.

Some of the key factors driving the critical care diagnostics market growth are, the rise in the incidence of chronic and infectious diseases, and the rise in the elderly population.

The Asia Pacific region held a substantial share of the market in 2020. The increase in the number of geriatrics population along with government reform is going to contribute significantly towards the growth of the critical care diagnostics market in the region.

Some of the major companies operating in the critical care diagnostics market are Abbott Laboratories, Siemens Healthineers, F. Hoffmann-La Roche Ltd., Dickinson and Company, Beckman Coulter, Inc., Alere, Inc., Bayer AG, Bio-Rad Laboratories, Inc., Danaher Corporation, and Chembio Diagnostic Systems, Inc., among others.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed